Showing results (71-80 of 79) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Clinical Toxicology|March 1, 1979
Abuse and pulmonary complications of injecting pentazocine and tripelennamine tabletsA J Butch, R A Yokel, L T Sigell, et al.Journal of Toxicology and Environmental Health|August 30, 1996
Aluminum toxicokineticsC Exley, E Burgess, J P Day, et al.Toxicology|April 11, 2001
Aluminum bioavailability from drinking water is very low and is not appreciably influenced by stomach contents or water hardnessR A Yokel, S S Rhineheimer, R D Brauer, et al.Journal of Pharmaceutical Sciences|March 29, 2000
The hexadentate hydroxypyridinonate TREN-(Me-3,2-HOPO) is a more orally active iron chelator than its bidentate analogueR A Yokel, A M Fredenburg, P W Durbin, et al.Brain Research|September 11, 1995
Delayed elevation of platelet activating factor in ischemic hippocampusL C Pettigrew, J J Meyer, S D Craddock, et al.Brain Research|July 21, 1999
Postmortem elevation in extracellular glutamate in the rat hippocampus when brain temperature is maintained at physiological levels: implications for the use of human brain autopsy tissuesJ W Geddes, N G Chang, D C Ackley, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 1, 1997
Short-term oral 3-hydroxypyridin-4-one dosing increases aluminum excretion and partially reverses aluminum-induced toxicity in the rabbit independent of chelator lipophilicityR A Yokel, K A Meurer, C B Hong, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1993
Pharmacokinetics of representative 3-hydroxypyridin-4-ones in rabbits: CP20 and CP94A M Fredenburg, P J Wedlund, T L Skinner, et al.Journal of Toxicology and Environmental Health|August 30, 1996
Prevention and treatment of aluminum toxicity including chelation therapy: status and research needsR A Yokel, P Ackrill, E Burgess, et al.Pageof 8